Expert Insights Podcast
Go beyond the written word with our new podcast series, featuring in-depth conversations with industry leaders shaping the future of drug development and delivery. Each episode explores real-world challenges, emerging technologies, and the insights driving innovation across the pharmaceutical landscape.
Mastering Analytics: LC-MS Analysis of Oligonucleotide Drugs
In this episode of Expert Insights, Drug Development & Delivery Managing Editor Cindy Dubin speaks with Dr. Melanie Zerulla-Wernitz, Head of Analytical Science Laboratory at Vetter, about the growing role of LC-MS in oligonucleotide characterization.
What Contamination Control Strategy (CCS) Means for Customer Confidence in Sterile Manufacturing
Contamination Control Strategy (CCS) shapes how sterile manufacturers and their suppliers demonstrate control over injectable drug products under Annex 1. In this video interview, Aptar Pharma’s Nicolas Voisin and Audrey Chardonnet explain what CCS means in daily operations, and how it translates into customer confidence.
Small Batches, Big Impact: The New Realities of CDMO Formulation Development
IN THIS MONTHS EXPERT INSIGHTS SPECIAL FEATURE WITH CINDY DUBIN - Are CDMOs really the heartbeat of the changing pharma landscape? Here's what we found...…
Enhancing Drug Bioavailability: Solubility Techniques and Innovations
Improving the bioavailability of poorly soluble drugs continues to be a critical focus in pharmaceutical development. Many active pharmaceutical ingredients (APIs), particularly those classified under…
Better Bioavailability Faster Timelines with Ascendia Pharmaceutical Solutions
In the rapidly evolving world of pharmaceuticals, understanding the intricacies of drug development is essential for anyone interested in healthcare innovation. In this episode of…
2026 Drug Development Outlook: What Industry Insiders Are Saying
In this new interview, veteran pharma journalist Cindy H. Dubin reveals the real shifts leaders are betting on for 2026: AI completely changing how drugs…
